Updated:
Inbio Ventures
Inbio Ventures is a management company for Pharmstandard International (Luxembourg), a private venture capital fund fully committed by PJSC Pharmstandard...
Overview
Inbio Ventures is a management company for Pharmstandard International (Luxembourg), a private venture capital fund fully committed by PJSC Pharmstandard (LSE: PHST). The firm has made three investments, including a Series B investment in Neon Therapeutics on January 05, 2017. Inbio Ventures has two portfolio exits, with TransMedics being the most recent on May 02, 2019.
General information
Firm type
Venture Capital
Year founded
2013
Location
Region
Europe
Country
Russia
City
Moscow
Corporate office
Moscow, Russia
Sector focus
Frequently asked questions
Which therapeutic areas does the firm prioritize?
Based on public record and the firm's stated life-science focus, Inbio Ventures invests across biotechnology platforms including oncology therapeutics, precision medicine diagnostics, and enabling drug-development tools. The firm draws from Russia's academic pipeline in molecular biology, immunology, and genetic research.
How does Inbio Ventures source its deal flow?
The firm sources opportunities through deep relationships within Russia's state-supported research institutes, particularly in Moscow, St. Petersburg, and Novosibirsk. This academic-embedded model grants visibility into laboratory-stage programs that are rarely marketed to international venture capital. Its scientist-founder network operates as a proprietary sourcing channel within a market that has limited cross-border biotech investment activity.
What is the geographic scope of the firm's investments?
The firm concentrates on Russia's three principal biotechnology clusters — Moscow, St. Petersburg, and Novosibirsk — with select exposure to technology spun out from academic centers elsewhere in the CIS region. This domestic geographic footprint reflects the sourcing model's dependence on local institutional trust and language-specific researcher relationships.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: